Although the underlying mechanism for association between dyslipidemia and the severity of systemic inflammation in KD remains unclear, a recent study by Zhang et al. [39] revealed that dyslipidemia during acute phase of KD was associated with aberrant levels of adipokines including adiponectin, omentin-1, and chemerin. The gene discussed is RARRES2; the disease is metabolic syndrome.